SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Mineralys Therapeutics, Inc.
@MLYS_InsiderForm 4 Filing: Rodman David Malcom Sells $17,459.52 of $MLYS
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
Mineralys Therapeutics, Inc.
Ticker: $MLYS
Transaction Value
$17,459.52
Price/Share: $20.98
transaction date
2026-07-17
Shares: 832
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rodman David Malcom, holds the title of Chief Medical Officer at Mineralys Therapeutics, Inc..
On 2026-07-17, the insider transacted 832 shares.The shares were transacted at a weighted average price of $20.98 per share, resulting in a total market-relevant value of $17,459.52.
Executive Summary Summary
Rodman David Malcom (Chief Medical Officer) sold $17K of $MLYS
Post-Transaction Position: 51,384 shares
SEC Accession No: 0001672659-26-000036 (CIK: 1672659)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.